Exaggerated activation of nuclear factor-κB and altered IκB-β processing in cystic fibrosis bronchial epithelial cells

被引:143
作者
Venkatakrishnan, A
Stecenko, AA
King, G
Blackwell, TR
Brigham, KL
Christman, JW
Blackwell, TS
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA
[2] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
关键词
D O I
10.1165/ajrcmb.23.3.3949
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In cystic fibrosis (CF), inflammatory mediator production by airway epithelial cells is a critical determinant of chronic airway inflammation. To determine whether altered signal transduction through the nuclear factor (NF)-kappa B pathway occurs in CF epithelial cells and results in excessive generation of inflammatory cytokines, we evaluated tumor necrosis factor (TNF)-alpha-induced production of the NF-kappa B-dependent cytokine interleukin (IL)-8 and activation of NF-KB in three different human bronchial epithelial cell lines: (1) BEAS cells that express wild-type CF transmembrane conductance regulator (CFTR), (2) IB3 cells with mutant CFTR, and (3) C38 cells, which are "corrected" IB3 cells complemented with wild-type CFTR, Treatment of cells with TNF-alpha (30 ng/ml) resulted in markedly elevated NF-kappa B activation and production of IL-8 by IB3 cells compared with BEAS and C38 cells. Despite the differences in NF-kappa B activation, no differences in basal levels of I kappa B-alpha or TNF-alpha-induced I kappa B-alpha processing and degradation were detected among the cell lines. In contrast, the basal level of I kappa B-beta was increased in the IB3 cells. Treatment with TNF-alpha resulted in increased formation of hypophosphorylated I kappa B-beta and increased nuclear localization of I kappa B-beta in IB3 cells compared with the other cell types, These findings provide additional evidence of a dysregulated inflammatory response in CF.
引用
收藏
页码:396 / 403
页数:8
相关论文
共 27 条
[11]   Activation of NF-κB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells [J].
DiMango, E ;
Ratner, AJ ;
Bryan, R ;
Tabibi, S ;
Prince, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2598-2605
[12]  
EZZELL C, 1997, J NIH RES, V9, P42
[13]   Inhibition of TNF-α-induced NF-κB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132 [J].
Fiedler, MA ;
Wernke-Dollries, K ;
Stark, JM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (02) :259-268
[14]  
KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075
[15]   BRONCHOALVEOLAR LAVAGE FINDINGS IN CYSTIC-FIBROSIS PATIENTS WITH STABLE, CLINICALLY MILD LUNG-DISEASE SUGGEST ONGOING INFECTION AND INFLAMMATION [J].
KONSTAN, MW ;
HILLIARD, KA ;
NORVELL, TM ;
BERGER, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (02) :448-454
[16]   PROMOTER ANALYSIS OF THE GENE ENCODING THE I-KAPPA-B-ALPHA/MAD3 INHIBITOR OF NF-KAPPA-B - POSITIVE REGULATION BY MEMBERS OF THE REL/NF-KAPPA-B FAMILY [J].
LEBAIL, O ;
SCHMIDTULLRICH, R ;
ISRAEL, A .
EMBO JOURNAL, 1993, 12 (13) :5043-5049
[17]  
MUKAIDA N, 1991, ADV EXP MED BIOL, V305, P31
[18]   A NOVEL SIGNAL-TRANSDUCTION PATHWAY FROM THE ENDOPLASMIC-RETICULUM TO THE NUCLEUS IS MEDIATED BY TRANSCRIPTION FACTOR NF-KAPPA-B [J].
PAHL, HL ;
BAEUERLE, PA .
EMBO JOURNAL, 1995, 14 (11) :2580-2588
[19]  
REDDEL RR, 1988, CANCER RES, V48, P1904
[20]   THE P65 SUBUNIT IS RESPONSIBLE FOR THE STRONG TRANSCRIPTION ACTIVATING POTENTIAL OF NF-KAPPA-B [J].
SCHMITZ, ML ;
BAEUERLE, PA .
EMBO JOURNAL, 1991, 10 (12) :3805-3817